Skip to content

Study · Not a test of the peptide alone · 1994

4 results

[Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].

Ivanova LA

Problemy tuberkuleza1 Jan 1994Cited by 2 (Europe PMC)

PMID7937662 (opens in a new tab)PepBankPUB-07937662
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In chronic pulmonary tuberculosis patients, immunological hormone therapy including thymalin increased T-lymphocyte count.

    In plain wordsIn tuberculosis patients, hormone and immune therapy including thymalin increased T-lymphocyte counts.

    Peptide
    Thymalin
    Outcome
    IncreaseT-lymphocyte count
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Immunological hormone therapy allows normalization of the immunological status (an increase in the count and functional activity of T-lymphocytes)
    1 context sentence
    Summary · context
    The paper provides the results of treatment of chronic pulmonary tuberculosis patients by using immunoactive drugs (thymalin and T-activin) and prednisolone, which has been performed by monitoring immunological parameters.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In chronic pulmonary tuberculosis patients, immunological hormone therapy including thymalin increased T-lymphocyte functional activity.

    In plain wordsIn tuberculosis patients, hormone and immune therapy including thymalin increased T-lymphocyte activity.

    Peptide
    Thymalin
    Outcome
    IncreaseT-lymphocyte functional activity
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Immunological hormone therapy allows normalization of the immunological status (an increase in the count and functional activity of T-lymphocytes)
    1 context sentence
    Summary · context
    The paper provides the results of treatment of chronic pulmonary tuberculosis patients by using immunoactive drugs (thymalin and T-activin) and prednisolone, which has been performed by monitoring immunological parameters.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In chronic pulmonary tuberculosis patients, immunological hormone therapy including thymalin produced relative disease stabilization.

    In plain wordsIn tuberculosis patients, hormone and immune therapy including thymalin produced relative disease stabilization.

    Peptide
    Thymalin
    Outcome
    Not applicableDisease stabilization
    Study

    n: not reported in source

    Outcome group
    Infection and antimicrobial activity · Respiratory

    Source sentences

    Summary
    and relative stabilization of the process
    1 context sentence
    Summary · context
    The paper provides the results of treatment of chronic pulmonary tuberculosis patients by using immunoactive drugs (thymalin and T-activin) and prednisolone, which has been performed by monitoring immunological parameters.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  4. 04HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In chronic pulmonary tuberculosis patients, immunological hormone therapy including thymalin shortened time to cessation of bacterial isolation versus controls.

    In plain wordsIn tuberculosis patients, hormone and immune therapy including thymalin stopped bacterial isolation sooner than in controls.

    Peptide
    Thymalin
    Outcome
    DecreaseTime to cessation of bacterial isolation
    Study

    n: not reported in source

    Comparator
    Controls
    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    with cessation of bacterial isolation in shorter periods than in the controls
    1 context sentence
    Summary · context
    The paper provides the results of treatment of chronic pulmonary tuberculosis patients by using immunoactive drugs (thymalin and T-activin) and prednisolone, which has been performed by monitoring immunological parameters.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.